Although plaque size remained similar to that in Apoe−/− donors, there was a 32% reduction in CD68+ macrophages, suggesting that antibiotics delay atherosclerosis inflammation resolution and that gut microbiota play a role in atherosclerosis inflammation (Garshick et al. 2021). This evidence concerns the gene CD68 and atherosclerosis.